fr

EN DE

fr

EN DE

Publications

2075 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2022

Journal of clinical medicine

Vovelle J

Prescription of Blood Lymphocyte Immunophenotyping in the Diagnosis of Lymphoid Neoplasms in Older Adults.

2022

International journal of molecular sciences

Niogret J

Association of Anti-EGFR Antibody and MEK Inhibitor in Gynecological Cancer Harboring RAS Mutation: A Case Series.

2022

Journal of vascular and interventional radiology : JVIR

Pierre-Alexis AUTRUSSEAU

Technique efficacy and safety following percutaneous cryoablation of extra-spinal thyroid cancer bone metastases with curative intent: single-center experience with a median follow-up of more than 5 years.

2022

iScience

Peralta M

Circulating tumor cells: Towards mechanical phenotyping of metastasis.

2022

Cancer imaging : the official publication of the International Cancer Imaging Society

Clément A

Multi-tracer and multiparametric PET imaging to detect the IDH mutation in glioma: a preclinical translational in vitro, in vivo, and ex vivo study.

2022

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Nicolae A

Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.

2022

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Kuntz L

Local recurrence and cerebral progression-free survival after multiple sessions of stereotactic radiotherapy of brain metastases: a retrospective study of 184 patients : Statistical analysis.

2022

Cancer immunology, immunotherapy : CII

Thibaudin M

Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer.

2022

Annals of oncology : official journal of the European Society for Medical Oncology

Basile D

Tumor budding is an independent prognostic factor in stage III colon cancer patients: A post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).

2022

The oncologist

Canton C

Impact of G-CSF Prophweylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma.